Matthew Sobo

607 total citations
8 papers, 494 citations indexed

About

Matthew Sobo is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Matthew Sobo has authored 8 papers receiving a total of 494 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Physiology. Recurrent topics in Matthew Sobo's work include Telomeres, Telomerase, and Senescence (3 papers), DNA Repair Mechanisms (2 papers) and Glioma Diagnosis and Treatment (2 papers). Matthew Sobo is often cited by papers focused on Telomeres, Telomerase, and Senescence (3 papers), DNA Repair Mechanisms (2 papers) and Glioma Diagnosis and Treatment (2 papers). Matthew Sobo collaborates with scholars based in United States, China and France. Matthew Sobo's co-authors include Stephanie Deangelis, Brian Hutzen, Jiayuh Lin, Sarah Ball, Li Lin, Pui‐Kai Li, Elizabeth Foust, Chenglong Li, Ling Cen and Mingxin Zuo and has published in prestigious journals such as British Journal of Cancer, Molecular Cancer Therapeutics and Cancer Science.

In The Last Decade

Matthew Sobo

8 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Sobo United States 7 274 253 92 83 60 8 494
Elizabeth Foust United States 5 295 1.1× 367 1.5× 138 1.5× 17 0.2× 14 0.2× 5 593
Jacqueline Sayyah United States 9 368 1.3× 178 0.7× 35 0.4× 67 0.8× 21 0.3× 11 534
Moacyr Oliveira United States 4 392 1.4× 237 0.9× 46 0.5× 47 0.6× 33 0.6× 4 593
Chu Myong Seong South Korea 12 360 1.3× 133 0.5× 20 0.2× 36 0.4× 31 0.5× 30 511
Cathy E. Nolan United States 6 384 1.4× 206 0.8× 117 1.3× 113 1.4× 32 0.5× 8 585
Moses Adeyanju United States 8 294 1.1× 143 0.6× 68 0.7× 44 0.5× 14 0.2× 8 471
Siti‐Faujiah Hendrayani Saudi Arabia 8 267 1.0× 339 1.3× 13 0.1× 28 0.3× 17 0.3× 8 532
Dayanand Deo United States 8 318 1.2× 242 1.0× 22 0.2× 28 0.3× 34 0.6× 15 537
Sara G. Manore United States 9 313 1.1× 256 1.0× 70 0.8× 29 0.3× 10 0.2× 13 579
Grace L. Wong United States 9 341 1.2× 229 0.9× 74 0.8× 29 0.3× 11 0.2× 13 578

Countries citing papers authored by Matthew Sobo

Since Specialization
Citations

This map shows the geographic impact of Matthew Sobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Sobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Sobo more than expected).

Fields of papers citing papers by Matthew Sobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Sobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Sobo. The network helps show where Matthew Sobo may publish in the future.

Co-authorship network of co-authors of Matthew Sobo

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Sobo. A scholar is included among the top collaborators of Matthew Sobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Sobo. Matthew Sobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kumar, Shiva Senthil, et al.. (2023). Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma. Frontiers in Oncology. 13. 1104670–1104670. 2 indexed citations
2.
Sobo, Matthew, Kyung-Woo Lee, Shiva Senthil Kumar, et al.. (2018). Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors. Molecular Cancer Therapeutics. 17(7). 1504–1514. 42 indexed citations
3.
Hummel, Trent R., Ralph Salloum, Rachid Drissi, et al.. (2015). A pilot study of bevacizumab-based therapy in patients with newly diagnosed high-grade gliomas and diffuse intrinsic pontine gliomas. Journal of Neuro-Oncology. 127(1). 53–61. 38 indexed citations
4.
Dorris, Kathleen, Matthew Sobo, Arzu Onar‐Thomas, et al.. (2014). Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas. Journal of Neuro-Oncology. 117(1). 67–76. 32 indexed citations
5.
Lin, Li, Brian Hutzen, Pui‐Kai Li, et al.. (2010). A Novel Small Molecule, LLL12, Inhibits STAT3 Phosphorylation and Activities and Exhibits Potent Growth-Suppressive Activity in Human Cancer Cells. Neoplasia. 12(1). 39–IN5. 166 indexed citations
6.
Fuh, Beng, Matthew Sobo, Brian Hutzen, et al.. (2009). LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model. British Journal of Cancer. 100(1). 106–112. 75 indexed citations
8.
Sobo, Matthew, Sarah Ball, Brian Hutzen, et al.. (2009). MI-63: A novel small-molecule inhibitor targets MDM2 and induces apoptosis in embryonal and alveolar rhabdomyosarcoma cells with wild-type p53. British Journal of Cancer. 101(5). 774–781. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026